Anteilseigner
Benjamin Shapiro (4,83 %) BML Capital Management LLC (2,08 %) Boothbay Fund Management LLC (1,70 %) Jess S. Morgan & Co., Inc. (0,90 %) Susquehanna Financial Group LLLP (0,85 %) Rathbones Investment Management Ltd. (0,72 %) Two Sigma Advisers LP (0,65 %) Merrill Lynch International (Investment Management) (0,64 %) KSM Mutual Funds Ltd. (0,36 %) Two Sigma Investments LP (0,33 %) Michael Rabinowitz (0,31 %) Renaissance Technologies LLC (0,30 %)
Kontakt
Oramed Pharmaceuticals Inc.
2 Elza Street
93706 Jerusalem